BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26335194)

  • 1. Psoralen, a mechanism-based inactivator of CYP2B6.
    Ji L; Lu D; Cao J; Zheng L; Peng Y; Zheng J
    Chem Biol Interact; 2015 Oct; 240():346-52. PubMed ID: 26335194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.
    Cao J; Zheng L; Ji L; Lu D; Peng Y; Zheng J
    Chem Biol Interact; 2015 Jan; 226():23-9. PubMed ID: 25500267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imperatorin is a mechanism-based inactivator of CYP2B6.
    Zheng L; Cao J; Lu D; Ji L; Peng Y; Zheng J
    Drug Metab Dispos; 2015 Jan; 43(1):82-8. PubMed ID: 25378064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6.
    Zhang K; Li Y; Fu Y; Cui T; Wang Q; Mao X; Peng Y; Zheng J
    Curr Drug Metab; 2021; 22(11):882-892. PubMed ID: 34191696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen.
    Lu D; Ji L; Zheng L; Cao J; Peng Y; Zheng J
    Xenobiotica; 2016; 46(4):335-41. PubMed ID: 26338349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
    Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of psoralen and isopsoralen as potent CYP1A2 reversible and time-dependent inhibitors in human and rat preclinical studies.
    Zhuang XM; Zhong YH; Xiao WB; Li H; Lu C
    Drug Metab Dispos; 2013 Nov; 41(11):1914-22. PubMed ID: 23975028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Chlorpyrifos.
    D'Agostino J; Zhang H; Kenaan C; Hollenberg PF
    Chem Res Toxicol; 2015 Jul; 28(7):1484-95. PubMed ID: 26075493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of α-terpinyl acetate on cytochrome P450 2B6 enzymatic activity.
    Lee Y; Park HG; Kim V; Cho MA; Kim H; Ho TH; Cho KS; Lee IS; Kim D
    Chem Biol Interact; 2018 Jun; 289():90-97. PubMed ID: 29723517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1',1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2007 Nov; 35(11):2053-9. PubMed ID: 17682072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of CYP2C9 by linderane.
    Wang H; Wang K; Mao X; Zhang Q; Yao T; Peng Y; Zheng J
    Xenobiotica; 2015; 45(12):1037-46. PubMed ID: 26068520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effects of Garcinia cambogia Extract on CYP2B6 Enzyme Activity.
    Yu JS; Choi MS; Park JS; Rehman SU; Nakamura K; Yoo HH
    Planta Med; 2017 Jul; 83(11):895-900. PubMed ID: 28288493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.
    Raunio H; Juvonen RO; Poso A; Lahtela-Kakkonen M; Rahnasto-Rilla M
    Drug Metab Lett; 2016; 10(1):56-64. PubMed ID: 26648056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
    Richter T; Mürdter TE; Heinkele G; Pleiss J; Tatzel S; Schwab M; Eichelbaum M; Zanger UM
    J Pharmacol Exp Ther; 2004 Jan; 308(1):189-97. PubMed ID: 14563790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel.
    Nishiya Y; Hagihara K; Ito T; Tajima M; Miura S; Kurihara A; Farid NA; Ikeda T
    Drug Metab Dispos; 2009 Mar; 37(3):589-93. PubMed ID: 19047469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins.
    Koenigs LL; Trager WF
    Biochemistry; 1998 Sep; 37(38):13184-93. PubMed ID: 9748325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.
    Chen C; Liu J; Halpert JR; Wilderman PR
    Biochemistry; 2018 Feb; 57(5):817-826. PubMed ID: 29215266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition.
    Kosaka M; Zhang D; Wong S; Yan Z
    Drug Metab Dispos; 2020 Aug; 48(8):655-661. PubMed ID: 32482757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.
    Liu Z; Li L; Wu H; Hu J; Ma J; Zhang QY; Ding X
    Drug Metab Dispos; 2015 Feb; 43(2):208-16. PubMed ID: 25409894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.